New stent graft under scrutiny for aortic repair
NCT ID NCT05639569
First seen May 30, 2026 · Last updated Jun 22, 2026 · Updated 4 times
Summary
This study follows 147 people with a thoracic aortic aneurysm or a type B aortic dissection who receive the Ankura stent graft system. The goal is to see how safe and effective the device is over three years. Researchers will track major complications and whether the stent graft stays in place and works properly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISSECTION OF THORACIC AORTA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
A.O. Ordine Mauriziano di Torino
Turin, Italy
-
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
-
Ankara Etlik City Hospital
Ankara, Turkey (Türkiye)
-
Ankara University Hospital Heart Center
Ankara, Turkey (Türkiye)
-
Asklepios Klinik Nord Heidberg
Hamburg, Germany
-
Erzurum University Hospital
Erzurum, Turkey (Türkiye)
-
Eskişehir City Hospital
Eskişehir, Turkey (Türkiye)
-
Evaggelismos General Hospital
Athens, Greece
-
Federal State Budgetary Institution - V.A. Almazov National Medical Research Centre
Saint Petersburg, Russia
-
Gaziantep City Hospital
Gaziantep, Turkey (Türkiye)
-
General Hospital of Athens - Georgios Gennimatas
Athens, Greece
-
Izmir City Hospital
Izmir, Turkey (Türkiye)
-
Petrovsky National Research Centre of Surgery
Moscow, Russia
-
St. Franziskus Hospital Münster
Münster, Germany
-
University General Hospital - Attikon
Attiki, Greece
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ankura TAA Stent Graft System (a device implanted to reinforce the aorta)
What this could lead to
If successful, this could confirm that the Ankura stent graft is a safe and effective option for treating thoracic aortic aneurysms and dissections.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. Risks include device-related complications like leaks or migration.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.